Skip to content
10-Q

Quarterly Report

MJ Pharmaceuticals Inc.

0001502629-15-000016

← back to feed
Filed
Jul 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Jul 15, 2015 185.74M sh
Operating Cash Flow Q2 2015 · Jun 30, 2015 −$13.24K
Operating Cash Flow Q2 2015 · Jun 30, 2014 −$8.52K
Stockholders Equity Q2 2015 · Jun 30, 2015 $5.33K
Stockholders Equity Q2 2015 · Dec 31, 2014 $6.91K
Stockholders Equity Q2 2015 · Dec 31, 2013 $0
Stockholders Equity Q2 2015 · Dec 31, 2012 $0
Current Liabilities Q2 2015 · Jun 30, 2015 $499
Current Liabilities Q2 2015 · Dec 31, 2014 $449
Current Assets Q2 2015 · Jun 30, 2015 $5.83K
Current Assets Q2 2015 · Dec 31, 2014 $7.36K
Total Assets Q2 2015 · Jun 30, 2015 $5.83K
Total Assets Q2 2015 · Dec 31, 2014 $7.36K
Eps Basic Q2 2015 · Jun 30, 2015 $0.00
Eps Basic Q2 2015 · Jun 30, 2015 $0.00
Eps Basic Q2 2015 · Jun 30, 2014 $0.00
Eps Basic Q2 2015 · Jun 30, 2014 $0.00
Net Income Q2 2015 · Jun 30, 2015 −$13.24K
Net Income Q2 2015 · Dec 31, 2014 −$7.68K
Net Income Q2 2015 · Jun 30, 2014 −$5.85K
Net Income Q2 2015 · Jun 30, 2014 −$8.52K
Net Income Q2 2015 · Dec 31, 2013 −$850
Net Income Q2 2015 · Dec 31, 2012 −$3.14K
Gross Profit Q2 2015 · Jun 30, 2015 $3.72K
Gross Profit Q2 2015 · Jun 30, 2014 $0
Gross Profit Q2 2015 · Jun 30, 2014 $0
Stock Issued Q2 2015 · Sep 30, 2014 25.62M sh
Cash And Equivalents Q2 2015 · Jun 30, 2014 $3.5K
Cash And Equivalents Q2 2015 · Dec 31, 2013 $0
Cash And Equivalents Q2 2015 · Feb 20, 2012 $0